02/19/2025
3:32 PM | Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/19/2025
3:32 PM | Eagle Pharmaceuticals (Subject)
Nantahala Capital Partners Limited Partnership (Filed by)
| Form SCHEDULE 13G | |
02/14/2025
8:01 AM | Eagle Pharmaceuticals (Subject)
Union Square Park Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
12/09/2024
11:15 PM | Eagle Pharmaceuticals (Filer)
| Form EFFECT | |
12/02/2024
3:17 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:05 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
11/27/2024
3:06 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
11/27/2024
3:06 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
11/27/2024
3:07 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
11/27/2024
3:07 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
11/27/2024
3:07 PM | Eagle Pharmaceuticals (Filer)
| Form S-8 POS | |
Get the Latest News and Ratings for EGRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/27/2024
3:08 PM | Eagle Pharmaceuticals (Filer)
| Form POS AM | |
11/27/2024
3:08 PM | Eagle Pharmaceuticals (Filer)
| Form RW | |
11/27/2024
8:25 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
6:59 PM | Eagle Pharmaceuticals (Issuer)
Krawtschuk Christopher (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/15/2024
4:19 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
10:34 AM | BRANDES INVESTMENT PARTNERS, LP (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/14/2024
9:25 AM | Eagle Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/13/2024
7:30 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
11/12/2024
6:08 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
3:32 PM | Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G/A | |
10/31/2024
12:36 PM | Eagle Pharmaceuticals (Subject)
Union Square Park Capital Management, LLC (Filed by)
| Form SC 13G/A | |
10/31/2024
7:50 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
3:05 PM | Eagle Pharmaceuticals (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
10/08/2024
11:42 AM | Eagle Pharmaceuticals (Subject)
Union Square Park Capital Management, LLC (Filed by)
| Form SC 13G | |
10/02/2024
8:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:30 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
3:35 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/05/2024
8:03 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
7:00 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Eagle Pharmaceuticals (Subject)
| Form SC 13G/A | |
07/03/2024
1:02 PM | Eagle Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13G | |
05/29/2024
7:20 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
8:08 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
8:29 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
4:27 PM | Eagle Pharmaceuticals (Filer)
| Form NT 10-Q | |
04/12/2024
3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:16 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
7:37 PM | Eagle Pharmaceuticals (Subject)
Tarriff Scott (Filed by)
| Form SC 13G/A | |
03/18/2024
7:00 AM | Eagle Pharmaceuticals (Filer)
| Form NT 10-K | |
03/08/2024
3:49 PM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The Real Hillbilly Elegy (Ad) The mountains of Appalachia are incredible to behold.
Spanning thousands of miles across Alabama, Kentucky, Tennessee and beyond…
It's one of our country’s most scenic areas. But hidden beneath the beauty is an ugly reality: our most beautiful land is also the poorest.
It’s a tragedy because for over 200 years, generation after generation has worked “coal country” with nothing but a pick and shovel, hauling billions of dollars from the ground. A bold new plan, hidden in Executive Order 14154… |
03/01/2024
3:40 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:35 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
7:23 PM | Cahill Brian Joseph (Reporting)
Eagle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:44 PM | Eagle Pharmaceuticals (Issuer)
Tarriff Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
7:09 AM | Eagle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free EGRX Stock Alerts